Phospho-MYL9 (Ser15) Polyclon
al Antibody（多克隆抗体） | Phospho-MYL9 (Ser15) Antibody | Phospho-MYL9 (Ser15)抗体- ￥2454
- CUSABIO
- 武汉
- CSB-PA098969
- 2026年03月28日
- ELISA, WB, IF
- Rabbit
- Human
企业认证
相关产品推荐更多 >
CNOT10 Polyclonal Antibody（多克隆抗体）, Biotin conjugated | CNOT10 Antibody, Biotin conjugated | CNOT10抗体, Biotin conjugated
￥880
NR3C1 (Ab-226) Polyclonal Antibody（多克隆抗体） | NR3C1 (Ab-226) Antibody | NR3C1 (Ab-226)抗体
￥2024
DAB2IP Polyclonal Antibody（多克隆抗体） | DAB2IP Antibody | DAB2IP抗体
￥1100
AGPAT3 Polyclonal Antibody（多克隆抗体）, Biotin conjugated | AGPAT3 Antibody, Biotin conjugated | AGPAT3抗体, Biotin conjugated
￥880
TTLL8 Polyclonal Antibody（多克隆抗体）, Biotin conjugated | TTLL8 Antibody, Biotin conjugated | TTLL8抗体, Biotin conjugated
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Peptide sequence around phosphorylation site of serine 15 (A-N-S(p)-N-V) derived from Human MLC2.
- 亚型：
IgG
- 形态：
liquid
- 保存条件：
-20°C or -80°C
- 克隆性：
多克隆
- 标记物：
Non-conjugated
- 适应物种：
Human
- 抗原来源：
12个月
- 目录编号：
Homo sapiens (Human)
- 供应商：
武汉研升生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA, WB, IF
- 靶点：
MYL9
- 抗体英文名：
Phospho-MYL9 (Ser15) Antibody
- 抗体名：
Phospho-MYL9 (Ser15) Antibody
- 规格：
100μl
|
Product Name |
Phospho-MYL9 (Ser15) Antibody |
|
Code |
CSB-PA098969 |
|
Aliases |
20 kDa myosin light chain antibody; Human 20kDa myosin light chain (MLC2) mRNA complete cds antibody; LC20 antibody; MGC3505 antibody; MLC 2 antibody; MLC-2C antibody; MLC2 antibody; MLY 9 antibody; MRLC1 antibody; MYL9 antibody; MYL9_HUMAN antibody; Myosin light chain 9 regulatory antibody; Myosin light polypeptide 9 regulatory antibody; myosin regulatory light chain 1 antibody; Myosin regulatory light chain 2 antibody; Myosin regulatory light chain 2 smooth muscle isoform antibody; Myosin regulatory light chain 9 antibody; Myosin regulatory light chain MRLC1 antibody; Myosin regulatory light polypeptide 9 antibody; Myosin RLC antibody; Myosin vascular smooth muscle light chain 2 antibody; MYRL2 antibody; OTTHUMP00000030857 antibody; smooth muscle isoform antibody |
|
Product Type |
Polyclonal Antibody |
|
Immunogen Species |
Homo sapiens (Human) |
|
Size |
100μl |
|
Uniprot ID |
P24844 |
|
Immunogen |
Peptide sequence around phosphorylation site of serine 15 (A-N-S(p)-N-V) derived from Human MLC2. |
|
Host Species |
Rabbit |
|
Species Reactivity |
Human |
|
Tested Applications |
ELISA, WB, IF; WB:1:500-1:1000 |
|
Clonality |
Polyclonal |
|
Isotype |
IgG |
|
Conjugate |
Non-conjugated |
|
Buffer |
Supplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
|
Form |
Liquid |
|
Stroage |
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
|
Purification Method |
Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi |
|
Target Names |
MYL9 |
|
Research Areas |
Cardiovascular;Signal transduction；Stem cells |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Using Phospho‐Motif Antibodies to Determine Kinase Substrates
comprising both the phosphorylated residue and the surrounding residues that determine kinase specificity, with degenerate residues taking up the remaining positions. Currently, several categories of phospho?motif antibody are commercially available
Optimized Protocol to Make Phospho-Specific Antibodies that Work
, not simply its level of expression. In this review, we will discuss both the design of the phosphopeptide immunogen and immunization. The affinity purification of the phospho-specific antibody as well as the methods most suitable for characterizing
Absorption Control in Immunohistochemistry Using Phospho-Peptides Immobilized on Magnetic Beads
neutralization of phospho-specific antibodies with phospho-peptides immobilized on magnetic beads. This technique allows for sequestration of antibody–peptide complex from the incubation solution, minimizing the risk of formation of unblocked antibodies capable
技术资料暂无技术资料 索取技术资料
